Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
387.50    0.00 (0.00%)
Bid:
380.00
Ask:
395.00
Spread: 15.00 (3.947%)
Market Cap: £185.99m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Director Appointment

24 Dec 2020 07:00

RNS Number : 7336J
Tristel PLC
24 December 2020
 

Tristel plc

("Tristel" or the "Company")

 

Director Appointment

 

Tristel plc (AIM: TSTL), leading manufacturer of infection prevention products, announces the appointment of Caroline Stephens to the Board as an Independent Non-Executive Director effective from 1 January 2021.

 

Caroline's executive career has been spent in global healthcare, marketing, and digital transformation, working for Johnson & Johnson for 26 years in multiple leadership roles.

 

Caroline holds a board advisory role with global digital transformation consultants CI&T.

 

It is expected that Caroline will join Tristel's Audit, Remuneration and Nomination committees.

 

Commenting on the appointment, Paul Swinney, CEO of Tristel, said: "I am delighted to welcome Caroline to the Board at such an exciting time for our Company. Caroline has extensive international and sector experience and we very much look forward to working with her."

 

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

 

Liz Dixon, Finance Director

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

finnCap

Tel: 020 7220 0500

Geoff Nash/ Giles Rolls (Corporate Finance)

 

Alice Lane (ECM)

 

   

 

 

Regulatory disclosure - The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

Caroline Jane Stephens, 53, holds no ordinary shares in the Company and no options. Caroline Stephen's current and previous directorships/partnerships are as follows:

 

Current Directorships/Partnerships:

Rex Bakery Ltd

Glendevon Trading Ltd

Verve Portfolio Ltd

 

Former Directorships/Partnerships held in last 5 years:

None

 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUOUVRROUUUAA
Date   Source Headline
9th Jun 20151:44 pmRNSTristel welcomes Cardiff University wipes study
3rd Jun 201512:20 pmRNSIssue of Equity
22nd May 201511:19 amRNSIssue of Equity
21st May 20157:00 amRNSTrading update
8th May 20157:00 amRNSIssue of Equity
4th Mar 20157:00 amRNSIssue of Equity/Director dealing
26th Feb 20157:01 amRNSInvestor Presentation
25th Feb 20157:00 amRNSHalf Yearly Report
6th Feb 20157:00 amRNSInvestor Results Presentation
28th Jan 20157:00 amRNSIssue of Equity
24th Dec 201411:27 amRNSGrant of Share Options
23rd Dec 20142:38 pmRNSDirector/PDMR Shareholding
16th Dec 201411:53 amRNSResult of AGM
16th Dec 20147:00 amRNSAGM Statement
21st Nov 20147:00 amRNSPosting of Annual Report & Notice of AGM
17th Nov 20143:27 pmRNSIssue of Equity
11th Nov 20147:00 amRNSNZ ENT study shows Tristel Wipes System benefits
3rd Nov 20146:02 pmRNSDirector's Shareholding
20th Oct 201411:56 amRNSIssue of Equity
13th Oct 20147:00 amRNSFinal Results
29th Sep 20147:00 amRNSInvestor Results Presentation
19th Aug 20147:00 amRNSMarket leadership in UK ENT market
28th Jul 20147:00 amRNSPre-close trading update
7th Jul 201410:03 amRNSIssue of Equity
23rd Jun 20148:30 amRNSIssue of Equity
18th Jun 201411:16 amRNSHolding(s) in Company
10th Jun 20147:00 amRNSTrading Update
22nd May 201412:37 pmRNSIssue of Equity
28th Apr 20147:00 amRNSTrading update
24th Apr 20147:00 amRNSSuccess in controlling Clostridium difficile rates
13th Mar 20147:00 amRNSPublic Health England tackle disease threats
3rd Mar 20147:01 amRNSGrant of Share Options
3rd Mar 20147:00 amRNSHalf Yearly Report
13th Feb 20147:00 amRNSInvestor Results Presentation
22nd Jan 20147:00 amRNSTrading Update and notice of results
10th Dec 20132:14 pmRNSResult of AGM
10th Dec 20137:00 amRNSAGM Statement
15th Nov 20137:00 amRNSPosting of Annual Report & Notice of AGM
18th Oct 20137:00 amRNSPeer-reviewed published article
14th Oct 20137:00 amRNSFinal Results
22nd Jul 20137:00 amRNSTrading Update & Notice of Results
28th May 20132:19 pmRNSDirector/PDMR Shareholding
29th Apr 20132:53 pmRNSHolding(s) in Company
15th Apr 20131:47 pmRNSHolding(s) in Company
10th Apr 201311:45 amRNSHolding(s) in Company
9th Apr 201311:18 amRNSDirectors' Shareholdings
21st Mar 20132:44 pmRNSHolding(s) in Company
4th Mar 20139:28 amRNSDirector Shareholding
4th Mar 20137:00 amRNSHalf Yearly Report
14th Feb 20137:00 amRNSTrading update and notice of results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.